Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level DLaboratory StudyPubMed
Compatibility of Hepatocyte Growth Factor, Adipose-Derived Mesenchymal Stem Cells, and Dermal Fillers for the Treatment of Vocal Fold Scar.
Laboratory Study on Scar, published in Stem Cell Rev Rep (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Rev Rep1 citations - Level DNarrative ReviewEurope PMC
Radiation-Induced Fibrosis in Head and Neck Cancer: Challenges and Future Therapeutic Strategies for Vocal Fold Treatments
Narrative Review on Chronic Inflammation, published in Cancers (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Cancers (Basel)7 citations - Level CProspective StudyEurope PMC
Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells-first phase I/II human clinical study
Prospective Study with a reported sample of 16 on Chronic Wound, Scar, Immune Modulation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
- n = 16
Stem Cell Res Ther29 citations - Level DNarrative ReviewPubMed
Pathophysiology of Fibrosis in the Vocal Fold: Current Research, Future Treatment Strategies, and Obstacles to Restoring Vocal Fold Pliability.
Narrative Review on Scar, Chronic Inflammation, published in Int J Mol Sci (2019) — summary generated from the PubMed abstract.
- 2019
Int J Mol Sci - Level DAnimal StudyEurope PMC
A tissue-specific, injectable acellular gel for the treatment of chronic vocal fold scarring
Animal Study on Chronic Wound, Scar, published in Acta Biomater (2019) — summary generated from the PubMed abstract.
- 2019
Acta Biomater23 citations - Level CProspective StudyEurope PMC
Efficacy of trans-nasal fiberendoscopic injection laryngoplasty with centrifuged autologous fat in the treatment of glottic insufficiency due to unilateral vocal fold paralysis
Prospective Study with a reported sample of 22, published in Acta Otorhinolaryngol Ital (2018) — summary generated from the PubMed abstract.
- 2018
- n = 22
Acta Otorhinolaryngol Ital16 citations - Level DNarrative ReviewEurope PMC
Current Treatment Options for Bilateral Vocal Fold Paralysis: A State-of-the-Art Review
Narrative Review on Scar, published in Clin Exp Otorhinolaryngol (2017) — summary generated from the PubMed abstract.
- 2017
Clin Exp Otorhinolaryngol57 citations - Level ASystematic ReviewEurope PMC
Mesenchymal Stem Cell Therapy for the Treatment of Vocal Fold Scarring: A Systematic Review of Preclinical Studies
Systematic Review with a reported sample of 152 on Scar, published in PLoS One (2016) — summary generated from the PubMed abstract.
- 2016
- n = 152
PLoS One18 citations - Level DNarrative ReviewPubMed
Perspectives on adipose-derived stem/stromal cells as potential treatment for scarred vocal folds: opportunity and challenges.
Narrative Review on Chronic Wound, Scar, published in Curr Stem Cell Res Ther (2010) — summary generated from the PubMed abstract.
- 2010
Curr Stem Cell Res Ther
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406